Article info
Discussion
Integrative clinical, genomics and metabolomics data analysis for mainstream precision medicine to investigate COVID-19
- Correspondence to Dr Zeeshan Ahmed, Rutgers Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, New Jersey 08901, USA; zahmed{at}ifh.rutgers.edu
Citation
Integrative clinical, genomics and metabolomics data analysis for mainstream precision medicine to investigate COVID-19
Publication history
- Received April 9, 2020
- Accepted August 13, 2020
- First published September 4, 2020.
Online issue publication
January 19, 2021
Article Versions
- Previous version (18 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage